Art

J-GLOBAL ID：200902280035377713   Reference number：07A0431949

Long-term cognitive benefits of donepezil in Alzheimer’s disease: A retrospective comparison between 1994-1999 and 2000-2004

Alzheimer病でのドネペジルの長期認識利点:1994~1999と2000~2004年の間の後ろ向き比較

Author (13)： TOMITA Naoki (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  OOTSUKI Mari (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  MARUYAMA Masahiro (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  MATSUI Toshifumi (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  HIGUCHI Miyako (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  TSUTSUI Miho (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  SEKI Takashi (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  IWASAKI Koh (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  TAMAMIZU Masako (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  SOZU Takashi (Tokyo Univ. Sci., Tokyo, JPN) ,  YOSHIMURA Isao (Tokyo Univ. Sci., Tokyo, JPN) ,  FURUKAWA Katsutoshi (Tohoku Univ. Graduate School of Medicine, Miyagi) ,  ARAI Hiroyuki (Tohoku Univ. Graduate School of Medicine, Miyagi)
Material： Geriatrics & Gerontology International  (Geriatrics and Gerontology International)
Volume： 7  Issue： 1  Page： 41-47  Publication year： Mar. 2007 
JST Material Number： W1574A  ISSN： 1444-1586  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： retrospective study

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=07A0431949&from=J-GLOBAL&jstjournalNo=W1574A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for nervous system diseases  (GN05020Y)

Substance index (1)： Donepezil

Reference (26)：

• HOMMA, A. Clinical efficacy and safety of donepezil on cognitive and global function in patients with Alzheimer's disease. A 24-week, multicenter, double-blind, placebo-controlled study in Japan. E2020 Study Group. Dement Geriatr Cogn Disord. 2000, 11, 299-313
• ROGERS, SL. A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group. Neurology. 1998, 50, 136-145
• ROGERS, SL. Donepezil improves cognition and global function in Alzheimer disease : a 15-week, double-blind, placebo-controlled study. Donepezil Study Group. Arch Intern Med. 1998, 158, 1021-1031
• WHITEHEAD, A. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease : a meta-analysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry. 2004, 19, 624-633
• LANCTOT, KL. Efficacy and safety of cholinesterase inhibitors in Alzheimer's disease : a meta-analysis. CMAJ. 2003, 169, 557-564

Terms in the title (4)： Alzheimer病 ,  ドネペジル ,  長期 ,  利点